Trials / Completed
CompletedNCT06133647
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- Methodist Health System · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- —
Summary
To determine the number of MBC cases as well as the demographics, characteristics, and outcomes of MBC patients at Methodist Health System (MHS).
Detailed description
Male breast cancer (MBC) is a rare disease without sufficient clinical data supporting the management and treatment. The treatment of MBC arises from data extrapolated from female breast cancer (FBC). MBC has higher mortality than FBC. Previous studies have suggested differences between MBC and FBC; however, treatments remain the same for both. Larger studies in MBC are needed to provide more clinical data to help guide treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | managing Male Breast Cancer Patients at Methodist Health System | To determine the number of MBC cases as well as the demographics, characteristics, and outcomes of MBC patients at Methodist Health System (MHS). |
Timeline
- Start date
- 2023-05-04
- Primary completion
- 2025-05-01
- Completion
- 2025-05-01
- First posted
- 2023-11-15
- Last updated
- 2026-03-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06133647. Inclusion in this directory is not an endorsement.